Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials

BACKGROUND: This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. METHODS: Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg twice daily or placebo, as monotherapy or with conventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesser, John, Gül, Ahmet, Olech, Ewa, Oelke, Kurt, Lukic, Tatjana, Kwok, Kenneth, Ebrahim, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621211/
https://www.ncbi.nlm.nih.gov/pubmed/37919780
http://dx.doi.org/10.1186/s13075-023-03154-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621211/
https://www.ncbi.nlm.nih.gov/pubmed/37919780
http://dx.doi.org/10.1186/s13075-023-03154-z

Ejemplares similares